Sandham, D. A., Barker, L., Brown, L., Brown, Z., Budd, D., Charlton, S. J., Chatterjee, D., Cox, B., Dubois, G., Duggan, N., Hall, E., Hatto, J., Maas, J., Manini, J., Profit, R., Riddy, D., Ritchie, C., Sohal, B., Shaw, D., Stringer, R., …Willis, J. (2017). Discovery of fevipiprant (NVP-QAW039), a potent and selective DP2 receptor antagonist for treatment of asthma. ACS Medicinal Chemistry Letters, 8(5), 582-586. https://doi.org/10.1021/acsmedchemlett.7b00157